MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
TLSI TriSalus Life Sciences
- 4.750
- +0.620+15.01%
Close Dec 24 13:00 ET
- 4.750
- 0.0000.00%
Post 17:01 ET
144.84MMarket Cap-2.48P/E (TTM)
4.750High4.142Low23.52KVolume4.350Open4.130Pre Close105.45KTurnover0.12%Turnover RatioLossP/E (Static)30.49MShares10.42052wk High-7.09P/B95.03MFloat Cap3.50052wk Low--Dividend TTM20.01MShs Float16.240Historical High--Div YieldTTM14.73%Amplitude3.320Historical Low4.484Avg Price1Lot Size
About TriSalus Life Sciences Company
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
Company Profile
SymbolTLSI
Company NameTriSalus Life Sciences
Listing DateFeb 8, 2021
Founded2020
CEOMs. Mary T. Szela
MarketNASDAQ
Employees112
Fiscal Year Ends12-31
Address6272 West 91st Avenue
CityWestminster
ProvinceColorado
CountryUnited States of America
Zip Code80031
Phone1-303-442-1222
Company Executives
- Name
- Position
- Salary
- Mary T. Szela
- Chief Executive Officer, President and Director
- 2.69M
- Jennifer Stevens
- Chief Regulatory Officer
- --
- Dr. Steven C. Katz, M.D.
- Chief Medical Officer
- 1.61M
- Sean E. Murphy
- Principal Accounting Officer, Director and Chief Financial Officer
- 1.39M
- James Young
- Senior Vice President, Investor Relations and Treasurer
- --
- Dr. Richard Marshak, V.M.D.
- Senior Vice President, Corporate Development, Strategy and Marketing
- --
- Mats L. Wahlstrom
- Chairman of the Board
- 323.28K
- Jodi Devlin
- President, Commercial Operations
- --
- Liselotte Hyveled
- Director
- --
- Kerry R. Hicks
- Independent Director
- 263.70K
- Dr. Arjun Desai, M.D.
- Independent Director
- 232.03K
- George Kelly Martin
- Independent Director
- 246.20K
- David J. Matlin
- Independent Director
- 234.12K
- Dr. Andrew C. von Eschenbach, M.D.
- Independent Director
- 234.95K
- Bryan F. Cox
- Chief of Research
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
